Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 4Phase 1 2Phase 4 1Phase 1/2 1

Status

Unknown 3Terminated 1

Sponsor Class

OTHER 4INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Breast 1

Conditions

Stomach Neoplasms 2Patient Compliance 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 182Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × OTHER × potassium oxonate × Clear all
NCT03448549 2020-03-06

SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients

Peking University Cancer Hospital & Institute

Phase 3 Unknown
1,191 enrolled
Gastrointestinal

Patient Compliance, Colorectal Neoplasms

NCT01655992 2018-01-23

A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)

Fudan University

Phase 3 Terminated
386 enrolled
Breast

Breast Neoplasms

NCT02008422 2013-12-11

Clinical Study of Endostar Injection Concomitant With SOX Protocols to Treat Advanced Gastric Cancer

Xinjiang Medical University

Phase 3 Unknown
120 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01198392 2011-07-25

Trial of S-1 Plus Cisplatin in Gastric Cancer

Sun Yat-sen University

Phase 3 Unknown
270 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡